English Intern
Lehrstuhl für klinische Epidemiologie und Biometrie

Prof. Dr. Dr. Götz Gelbrich

Prof. Dr. Dr. Götz Gelbrich

Professor für Biometrie, stellvertretende Leitung Lehrstuhl
Am Schwarzenberg Haus A15 / A15 4.310

kurzer Lebenslauf

seit 2012 Professor (W2) für Biometrie und stellvertretender Leiter Lehrstuhl für Klinische Epidemiologie und Biometrie, Universität Würzburg
2011 Venia legendi für Medizinische Biometrie und Epidemiologie, Universität Leipzig
2008 Promotion zum Dr. rer. med. (summa cum laude), Universität Leipzig
seit 2003 Seniorbiometriker des Kompetenznetzes Herzinsuffizienz 
1999-2012 Biometriker am Zentrum für Klinische Studien Leipzig, Universität Leipzig
1995 Promotionspreis der Gesellschaft von Freunden und Förderern der Ernst-Moritz-Arndt-Universität Greifswald e.V.
1994             Promotion zum Dr. rer. nat. (summa cum laude), Universität Greifswald
1990-1999 wissenschaftlicher Asistent am Institut für Mathematik und Informatik, Universität Greifswald
1990 mgr matematyki (mit Auszeichnung), Universität Warschau
1985-1990 Diplomstudium der Mathematik, Universität Warschau

 

Wissenschaftliche Schwerpunkte

Biometrie, klinische Studien, Studiendesign, klinische Epidemiologie

Hauptpublikationen der letzten Jahre

2024[ to top ]
  • 1.
    Blickle M, Klüpfel C, Homola GA, Gamer M, Herrmann MJ, Störk S, Gelbrich G, Heuschmann PU, Deckert J, Pham M, Menke A. Heart rate variability, interoceptive accuracy and functional connectivity in middle-aged and older patients with depression. J Psychiatr Res. 2024;170:122-9.
  • 1.
    Sahiti F, Cejka V, Schmidbauer L, Albert J, Kerwagen F, Frantz S, Gelbrich G, Heuschmann PU, Störk S, Morbach C, Maack C, Ertl G, Wanner C, Leyh R, Volkmann J, Deckert J, Faller H, Jahns R. Prognostic Utility of Pericardial Effusion in the General Population: Findings From the STAAB Cohort Study. Journal of the American Heart Association [Internet]. 2024;:e035549. Available from: https://www.ahajournals.org/doi/abs/10.1161/JAHA.124.035549
  • 1.
    Morbach C, Moser N, Cejka V, Stach M, Sahiti F, Kerwagen F, Frantz S, Pryss R, Gelbrich G, Heuschmann PU, Störk S. Determinants and reference values of the 6-min walk distance in the general population-results of the population-based STAAB cohort study. Clin Res Cardiol. 2024;.
  • 1.
    Morbach C, Gelbrich G, Schreckenberg M, Hedemann M, Pelin D, Scholz N, Miljukov O, Wagner A, Theisen F, Hitschrich N, Wiebel H, Stapf D, Karch O, Frantz S, Heuschmann PU, Störk S. Population data-based federated machine learning improves automated echocardiographic quantification of cardiac structure and function: the Automatisierte Vermessung der Echokardiographie project. Eur Heart J Digit Health. 2024;5(1):77-88.
2023[ to top ]
  • 1.
    Kleineidam L, Stark M, Riedel-Heller SG, Pabst A, Schmiedek F, Streit F, Rietschel M, Klinger-König J, Grabe HJ, Erhardt A, Gelbrich G, Schmidt B, Berger K, Wagner M. The assessment of cognitive function in the German National Cohort (NAKO) - Associations of demographics and psychiatric symptoms with cognitive test performance. World J Biol Psychiatry. 2023;24(10):909-23.
  • 1.
    Erhardt A, Gelbrich G, Klinger-König J, Streit F, Kleineidam L, Riedel-Heller SG, Schmidt B, Schmiedek F, Wagner M, Grabe HJ, Rietschel M, Berger K, Deckert J. Generalised anxiety and panic symptoms in the German National Cohort (NAKO). World J Biol Psychiatry. 2023;24(10):881-96.
  • 1.
    Gelbrich G, Morbach C, Deutschbein T, Fassnacht M, Störk S, Heuschmann PU. The Population Comparison Index: An Intuitive Measure to Calibrate the Extent of Impairments in Patient Cohorts in Relation to Healthy and Diseased Populations. Int J Environ Res Public Health. 2023;20(3).
  • 1.
    Lichter K, Klüpfel C, Stonawski S, Hommers L, Blickle M, Burschka C, Das F, Heißler M, Hellmuth A, Helmel J, Kranemann L, Lechner K, Lehrieder D, Sauter A, Schiele MA, Vijayakumar V, von Broen M, Weiß C, Morbach C, Störk S, Gelbrich G, Heuschmann PU, Higuchi T, Buck A, Homola GA, Pham M, Menke A, Domschke K, Kittel-Schneider S, Deckert J. Deep phenotyping as a contribution to personalized depression therapy: the GEParD and DaCFail protocols. J Neural Transm (Vienna). 2023;130(5):707-22.
  • 1.
    Uhe T, Wasser K, Weber-Krüger M, Schäbitz WR, Köhrmann M, Brachmann J, Laufs U, Dichgans M, Gelbrich G, Petroff D, Prettin C, Michalski D, Kraft A, Etgen T, Schellinger PD, Soda H, Bethke F, Ertl M, Kallmünzer B, Grond M, Althaus K, Hamann GF, Mende M, Wagner M, Gröschel S, Uphaus T, Gröschel K, Wachter R. Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism-the Find-AF 2 study-rationale and design. Am Heart J. 2023;265:66-7.
2022[ to top ]
  • 1.
    Kleineidam L, Stark M, Riedel-Heller SG, Pabst A, Schmiedek F, Streit F, Rietschel M, Klinger-König J, Grabe HJ, Erhardt A, Gelbrich G, Schmidt B, Berger K, Wagner M. The assessment of cognitive function in the German National Cohort (NAKO) - Associations of demographics and psychiatric symptoms with cognitive test performance. World J Biol Psychiatry. 2022;:1-15.
  • 1.
    Morbach C, Hoffmann K, Sahiti F, Detomas M, Eichner F, Kroiss M, Gelbrich G, Frantz S, Fassnacht M, Heuschmann P, Hahner S, Stoerk S, Deutschbein T. Mild autonomous cortisol secretion portends similar cardiac compromise as overt endogenous Cushings syndrome. European Heart Journal - Cardiovascular Imaging [Internet]. 2022;23(Supplement_1). Available from: https://doi.org/10.1093/ehjci/jeab289.178
  • 1.
    Sahiti F, Morbach C, Ehrlich K, Detomas M, Kroiss M, Lengenfelder B, Gelbrich G, Frantz S, Fassnacht M, Heuschmann P, Hahner S, Stoerk S, Deutschbein T. Endogenous Cushings syndrome is associated with impaired myocardial work efficiency. European Heart Journal - Cardiovascular Imaging [Internet]. 2022;23(Supplement_1). Available from: https://doi.org/10.1093/ehjci/jeab289.166
  • 1.
    Erhardt A, Gelbrich G, Klinger-König J, Streit F, Kleineidam L, Riedel-Heller SG, Schmidt B, Schmiedek F, Wagner M, Grabe HJ, Rietschel M, Berger K, Deckert J. Generalised anxiety and panic symptoms in the German National Cohort (NAKO). World J Biol Psychiatry. 2022;:1-16.
2021[ to top ]
  • 1.
    Sahiti F, Morbach C, Cejka V, Albert J, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Left Ventricular Remodeling and Myocardial Work: Results From the Population-Based STAAB Cohort Study. Front Cardiovasc Med. 2021;8:669335.
  • 1.
    Sahiti F, Morbach C, Cejka V, Tiffe T, Wagner M, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Impact of cardiovascular risk factors on myocardial work—insights from the STAAB cohort study. Journal of Human Hypertension [Internet]. 2021;36(3):235-4. Available from: https://doi.org/10.1038/s41371-021-00509-4
  • 1.
    Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig SJ, Morbach C, Reese JP, Störk S, Fricke J, Zoller T, Schmidt S, Triller P, Kretzler L, Rönnefarth M, Von Kalle C, Willich SN, Kurth F, Steinbeis F, Witzenrath M, Bahmer T, Hermes A, Krawczak M, Reinke L, Maetzler C, Franzenburg J, Enderle J, Flinspach A, Vehreschild J, Schons M, Illig T, Anton G, Ungethüm K, Finkenberg BC, Gehrig MT, Savaskan N, Heuschmann PU, Keil T, Schreiber S. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • 1.
    Eichner FA, Gelbrich G, Weißbrich B, Dölken L, Kurzai O, Deckert J, Ertl G, Barth M, Hein G, Neuhauser H. Seroprävalenz von COVID-19 und psychosoziale Auswirkungen in der Allgemeinbevölkerung: Ergebnisse des STAAB-COVID-One Programms. Das Gesundheitswesen. 2021;83(12):965-7.
  • 1.
    Fleischer A, Heimeshoff L, Allgaier J, Jordan K, Gelbrich G, Pryss R, Schobel J, Einsele H, Kortuem M, Maatouk I, Weinhold N, Rasche L. Is PFS the Right Endpoint to Assess Outcome of Maintenance Studies in Multiple Myeloma? Results of a Patient Survey Highlight Quality-of-Life As an Equally Important Outcome Measure. Blood [Internet]. 2021;138:836. Available from: https://www.sciencedirect.com/science/article/pii/S000649712102824X
  • 1.
    Morbach C, Gelbrich G, Tiffe T, Eichner FA, Christa M, Mattern R, Breunig M, Cejka V, Wagner M, Heuschmann PU, Störk S, consortium the S. Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study. European Journal of Preventive Cardiology [Internet]. 2021;28(9):924-3. Available from: https://doi.org/10.1177/2047487320922636
  • 1.
    Lange F, Roothans J, Wichmann T, Gelbrich G, Röser C, Volkmann J, Reich M. DIPS (Dystonia Image-based Programming of Stimulation: a prospective, randomized, double-blind crossover trial). Neurological Research and Practice [Internet]. 2021;3(1):65. Available from: https://doi.org/10.1186/s42466-021-00165-6
  • 1.
    Yurdadogan T, Malsch C, Kotseva K, Wood D, Leyh R, Ertl G, Karmann W, Müller-Scholden L, Morbach C, Breunig M, Wagner M, Gelbrich G, Bots ML, Heuschmann PU, Störk S. Functional versus morphological assessment of vascular age in patients with coronary heart disease. Scientific Reports [Internet]. 2021;11(1):18164. Available from: https://doi.org/10.1038/s41598-021-96998-x
2020[ to top ]
  • 1.
    Morbach C, Sahiti F, Tiffe T, Cejka V, Eichner FA, Gelbrich G, Heuschmann PU, Störk S. Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study. PLoS One. 2020;15(10):e0239684.
  • 1.
    Schlagenhauf U, Rehder J, Gelbrich G, Jockel-Schneider Y. Consumption of Lactobacillus reuteri-containing lozenges improves periodontal health in navy sailors at sea: A randomized controlled trial. Journal of Periodontology [Internet]. 2020;91(10):1328-3. Available from: https://aap.onlinelibrary.wiley.com/doi/abs/10.1002/JPER.19-0393
  • 1.
    Gelbrich B, Carl C, Gelbrich G. Comparison of three methods to estimate dental age in children. Clin Oral Investig. 2020;24(7):2469-75.
  • 1.
    Wasser K, Weber-Krüger M, Gröschel S, Uphaus T, Liman J, Hamann GF, Kermer P, Seegers J, Binder L, Gelbrich G, Gröschel K, Wachter R. Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke. Stroke [Internet]. 2020;51(2):395-401. Available from: https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.119.026496
2019[ to top ]
  • 1.
    Morbach C, Gelbrich G, Tiffe T, Eichner F, Wagner M, Heuschmann PU, Störk S, Frantz S, Maack C, Ertl G, Fassnacht M, Wanner C, Leyh R, Volkmann J, Deckert J, Faller H, Jahns R. Variations in cardiovascular risk factors in people with and without migration background in Germany – Results from the STAAB cohort study. International Journal of Cardiology [Internet]. 2019;286:186-9. Available from: https://www.sciencedirect.com/science/article/pii/S0167527318341305
  • 1.
    Tiffe T, Morbach C, Malsch C, Gelbrich G, Wahl V, Wagner M, Kotseva K, Wood D, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU. Physicians’ lifestyle advice on primary and secondary cardiovascular disease prevention in Germany: A comparison between the STAAB cohort study and the German subset of EUROASPIRE IV. Eur J Prev Cardiol. 2019;:2047487319838218.
  • 1.
    Diekmann S, Hörster L, Evers S, Hiligsmann M, Gelbrich G, Gröschel K, Wachter R, Hamann GF, Kermer P, Liman J, Weber-Krüger M, Wasem J, Neumann A. Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients. Current Medical Research and Opinion [Internet]. 2019;35(11):1859-66. Available from: https://doi.org/10.1080/03007995.2019.1646000
  • 1.
    Müller-Scholden L, Kirchhof J, Morbach C, Breunig M, Meijer R, Rücker V, Tiffe T, Yurdadogan T, Wagner M, Gelbrich G, Bots ML, Störk S, Heuschmann PU. Segment-specific association of carotid-intima-media thickness with cardiovascular risk factors - findings from the STAAB cohort study. BMC Cardiovasc Disord. 2019;19(1):84.
  • 1.
    Dufner V, Sayehli CM, Chatterjee M, Hummel HD, Gelbrich G, Bargou RC, Goebeler ME. Long-term outcome of patients with relapsed/refractory B-cell non-Hodgkin lymphoma treated with blinatumomab. Blood Advances [Internet]. 2019;3(16):2491-8. Available from: https://doi.org/10.1182/bloodadvances.2019000025
  • 1.
    Morbach C, Walter BN, Breunig M, Liu D, Tiffe T, Wagner M, Gelbrich G, Heuschmann PU, Störk S. Speckle tracking derived reference values of myocardial deformation and impact of cardiovascular risk factors - Results from the population-based STAAB cohort study. PLoS One. 2019;14(9):e0221888.
  • 1.
    Tiffe T, Morbach C, Rücker V, Gelbrich G, Wagner M, Faller H, Störk S, Heuschmann PU. Impact of Patient Beliefs on Blood Pressure Control in the General Population: Findings from the Population-Based STAAB Cohort Study. Int J Hypertens. 2019;2019:9385397.
2018[ to top ]
  • 1.
    Bobenko A, Bartels I, Münch M, Trippel T, Lindhorst R, Nolte K, Herrmann-Lingen C, Halle M, Duvinage A, Düngen HD, Gelbrich G, Tschöpe C, Hasenfuss G, Wachter R, Pieske B, Edelmann F. Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction. ESC Heart Failure [Internet]. 2018;5(1):53-62. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.12227
  • 1.
    Krone M, Dufner V, Wagner M, Gelbrich G, Ertl G, Heuschmann PU. Public funding for medical research in relation to the burden of disease caused by cardiovascular diseases and neoplasms in Germany. Clin Res Cardiol. 2018;107(9):737-44.
  • 1.
    Wagner M, Gelbrich G, Kircher J, Kotseva K, Wood D, Morbach C, Leyh R, Ertl G, Karmann W, Störk S, Heuschmann PU. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey. Int J Behav Med. 2018;25(3):283-9.
  • 1.
    Weber-Krueger M, Gelbrich G, Liman J, Hamann GF, Kermer P, Gröschel K, Wachter R. Abstract WP201: Stroke Patients With Atrial Fibrillation Detected by 72 hour- versus Prolonged ECG-monitoring. Stroke [Internet]. 2018;49(Suppl_1):AWP201-AWP201. Available from: https://www.ahajournals.org/doi/abs/10.1161/str.49.suppl_1.WP201
  • 1.
    Löhr M, Freitag B, Technau A, Krauss J, Monoranu CM, Rachor J, Lutz MB, Hagemann C, Kessler AF, Linsenmann T, Wölfl M, Ernestus RI, Engelhardt S, Gelbrich G, Schlegel PG, Eyrich M. High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T(reg) depletion. Cancer Immunol Immunother. 2018;67(10):1545-58.
  • 1.
    Morbach C, Gelbrich G, Breunig M, Tiffe T, Wagner M, Heuschmann PU, Störk S. Impact of acquisition and interpretation on total inter-observer variability in echocardiography: results from the quality assurance program of the STAAB cohort study. The International Journal of Cardiovascular Imaging [Internet]. 2018;34(7):1057-65. Available from: https://doi.org/10.1007/s10554-018-1315-3
2017[ to top ]
  • 1.
    Wachter R, Gröschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers J, Wasser K, Schulte A, Jürries F, Messerschmid A, Behnke N, Gröschel S, Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko E, Heuschmann PU, Conen D, Weber-Krüger M. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF(RANDOMISED)): an open-label randomised controlled trial. Lancet Neurol. 2017;16(4):282-90.
  • 1.
    Tiffe T, Wagner M, Rücker V, Morbach C, Gelbrich G, Störk S, Heuschmann PU. Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study. BMC Cardiovasc Disord. 2017;17(1):276.
2016[ to top ]
  • 1.
    Angermann CE, Gelbrich G, Störk S, Gunold H, Edelmann F, Wachter R, Schunkert H, Graf T, Kindermann I, Haass M, Blankenberg S, Pankuweit S, Prettin C, Gottwik M, Böhm M, Faller H, Deckert J, Ertl G, Members MHSI, Committee. Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial. Jama. 2016;315(24):2683-93.
  • 1.
    Wagner M, Tiffe T, Morbach C, Gelbrich G, Störk S, Heuschmann PU, STAAB-Consortium. Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression - design and rationale of the STAAB cohort study. Eur J Prev Cardiol. 2016;24(5):468-79.
  • 1.
    Hummel M, Perez J, Hagen R, Gelbrich G, Ernestus RI, Matthies C. Auditory Monitoring in Vestibular Schwannoma Surgery: Intraoperative Development and Outcome. World Neurosurg. 2016;96:444-53.
  • 1.
    Musacchio T, Purrer V, Papagianni A, Fleischer A, Mackenrodt D, Malsch C, Gelbrich G, Steigerwald F, Volkmann J, Klebe S. Non-Motor Symptoms of Essential Tremor Are Independent of Tremor Severity and Have an Impact on Quality of Life. Tremor Other Hyperkinet Mov (N Y). 2016;6:361.
  • 1.
    Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, Inkrot S, Loncar G, Tahirovic E, Celic V, Veskovic J, Zdravkovic M, Lainscak M, Apostolović S, Neskovic AN, Pieske B, Düngen HD, Failure CEI, in the Competence Network Heart PMT. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. JACC Heart Fail. 2016;4(2):140-9.
  • 1.
    Lange J, Weil F, Riegler C, Groeber F, Rebhan S, Kurdyn S, Alb M, Kneitz H, Gelbrich G, Walles H, Mielke S. Interactions of donor sources and media influence the histo-morphological quality of full-thickness skin models. Biotechnol J. 2016;11(10):1352-61.
  • 1.
    Jahandar Lashki D, Zelenak C, Tahirovic E, Trippel TD, Kolip P, Busjahn A, Rauchfuß M, Nolte K, Schwarz S, Wachter R, Gelbrich G, Halle M, Pieske B, Herrmann-Lingen C, Edelmann F, Düngen HD. [Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire]. Herz. 2016;42(2):200-8.
  • 1.
    Hummel M, Perez J, Hagen R, Gelbrich G, Ernestus RI, Matthies C. When Does Hearing Loss Occur in Vestibular Schwannoma Surgery? Importance of Auditory Brainstem Response Changes in Early Postoperative Phase. World Neurosurg. 2016;95:91-8.
2015[ to top ]
  • 1.
    Gelbrich B, Frerking C, Weiß S, Schwerdt S, Stellzig-Eisenhauer A, Tausche E, Gelbrich G. Combining wrist age and third molars in forensic age estimation: how to calculate the joint age estimate and its error rate in age diagnostics*. Annals of Human Biology [Internet]. 2015;42(4):389-96. Available from: https://doi.org/10.3109/03014460.2015.1046487
  • 1.
    Pankuweit S, Lüers C, Richter A, Ruppert V, Gelbrich G, Maisch BCNHF. Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy. Eur J Clin Invest. 2015;45(9):906-17.
  • 1.
    Faller H, Störk S, Gelbrich G, Schowalter M, Ertl G, Angermann CE. Depressive symptoms in heart failure: Independent prognostic factor or marker of functional status?. J Psychosom Res. 2015;78(6):569-72.
  • 1.
    Piepenburg SM, Faller H, Gelbrich G, Störk S, Warrings B, Ertl G, Angermann CE. Comparative potential of the 2-item versus the 9-item patient health questionnaire to predict death or rehospitalization in heart failure. Circ Heart Fail. 2015;8(3):464-72.
  • 1.
    Gelbrich B, Schwerdt S, Hirsch A, Dannhauer KH, Tausche E, Gelbrich G. Verschiedene Gesichter der Altersschätzung: Methodische Betrachtungen aus der Sicht einzelner Disziplinen. Rechtsmedizin. 2015;25:7-11.
  • 1.
    Güder G, Gelbrich G, Edelmann F, Wachter R, Pieske B, Pankuweit S, Maisch B, Prettin C, Brenner S, Morbach C, Berliner D, Deubner N, Ertl G, Angermann CE, Störk S, Germany CNHF. Reverse epidemiology in different stages of heart failure. Int J Cardiol. 2015;184:216-24.
  • 1.
    Inkrot S, Lainscak M, Edelmann F, Loncar G, Stankovic I, Celic V, Apostolovic S, Tahirovic E, Trippel T, Herrmann-Lingen C, Gelbrich G, Düngen HD. Poor self-rated health predicts mortality in patients with stable chronic heart failure. Eur J Cardiovasc Nurs. 2015;15(7):504-12.
  • 1.
    Seegers J, Zabel M, Grüter T, Ammermann A, Weber-Krüger M, Edelmann F, Gelbrich G, Binder L, Herrmann-Lingen C, Gröschel K, Hasenfuß G, Feltgen N, Pieske B, Wachter R. Natriuretic peptides for the detection of paroxysmal atrial fibrillation. Open Heart [Internet]. 2015;2(1):e000182. Available from: http://openheart.bmj.com/content/2/1/e000182.abstract
  • 1.
    Dekleva M, Lazic JS, Soldatovic I, Inkrot S, Arandjelovic A, Waagstein F, Gelbrich G, Cvijanovic D, Dungen HD. Improvement of Ventricular-Arterial Coupling in Elderly Patients with Heart Failure After Beta Blocker Therapy: Results from the CIBIS-ELD Trial. Cardiovasc Drugs Ther. 2015;29(3):287-94.
  • 1.
    Edelmann F, Holzendorf V, Wachter R, Nolte K, Schmidt AG, Kraigher-Krainer E, Duvinage A, Unkelbach I, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Stough WG, Pieske BM. Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial. Eur J Heart Fail. 2015;17(2):214-23.
  • 1.
    Neumann A, Mostardt S, Biermann J, Gelbrich G, Goehler A, Geisler BP, Siebert U, Störk S, Ertl G, Angerrmann CE, Wasem J. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study. Clin Res Cardiol. 2015;104(4):304-9.
  • 1.
    Nolte K, Herrmann-Lingen C, Wachter R, Gelbrich G, Düngen HD, Duvinage A, Hoischen N, von Oehsen K, Schwarz S, Hasenfuss G, Halle M, Pieske B, Edelmann F. Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol. 2015;22(5):582-93.
  • 1.
    Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Eur J Heart Fail. 2015;17(4):442-52.
2014[ to top ]
  • 1.
    Weber-Krüger M, Gelbrich G, Stahrenberg R, Liman J, Kermer P, Hamann GF, Seegers J, Gröschel K, Wachter R, investigators FA. Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring--Find-AF(RANDOMISED) --rationale and design. Am Heart J. 2014;168(4):438-445.e1.
  • 1.
    Pilz S, Edelmann F, Meinitzer A, Gelbrich G, Döner U, Düngen HD, Tomaschitz A, Kienreich K, Gaksch M, Duvinage A, Stahrenberg R, Kunde J, Schmidt A, März W, Wachter R, Pieske B. Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction. J Card Fail. 2014;20(12):923-30.
  • 1.
    Schneider A, Gutjahr-Lengsfeld L, Ritz E, Scharnagl H, Gelbrich G, Pilz S, Macdougall IC, Wanner C, Drechsler C. Longitudinal assessments of erythropoietin-stimulating agent responsiveness and the association with specific clinical outcomes in dialysis patients. Nephron Clin Pract. 2014;128(1-2):147-52.
  • 1.
    Apostolovic S, Stanojevic D, Lainscak M, Gelbrich G, Jankovic-Tomasevic R, Pavlovic M, Djordjevic-Radojkovic D, Salinger-Martinovic S, Putnikovic B, Radovanovic S, Waagstein F, Tomasevic M, Tahirovic E, Inkrot S, Musial-Bright L, Düngen HD. Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD). Cardiol J. 2014;21(3):265-72.
  • 1.
    Meder B, Rühle F, Weis T, Homuth G, Keller A, Franke J, Peil B, Lorenzo Bermejo J, Frese K, Huge A, Witten A, Vogel B, Haas J, Völker U, Ernst F, Teumer A, Ehlermann P, Zugck C, Friedrichs F, Kroemer H, Dörr M, Hoffmann W, Maisch B, Pankuweit S, Ruppert V, Scheffold T, Kühl U, Schultheiss HP, Kreutz R, Ertl G, Angermann C, Charron P, Villard E, Gary F, Isnard R, Komajda M, Lutz M, Meitinger T, Sinner MF, Wichmann HE, Krawczak M, Ivandic B, Weichenhan D, Gelbrich G, El-Mokhtari NE, Schreiber S, Felix SB, Hasenfuß G, Pfeufer A, Hübner N, Kääb S, Arbustini E, Rottbauer W, Frey N, Stoll M, Katus HA. A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy. Eur Heart J. 2014;35(16):1069-77.
  • 1.
    Gelbrich G, Störk S, Kreißl-Kemmer S, Faller H, Prettin C, Heuschmann PU, Ertl G, Angermann CE. Effects of structured heart failure disease management on mortality and morbidity depend on patients’ mood: results from the Interdisciplinary Network for Heart Failure Study. Eur J Heart Fail. 2014;16(10):1133-41.
  • 1.
    Düngen HD, Musial-Bright L, Inkrot S, Apostolović S, Edelmann F, Lainščak M, Sekularac N, Störk S, Tahirovic E, Tscholl V, Krackhardt F, Loncar G, Trippel TD, Gelbrich G. Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial. Eur J Heart Fail. 2014;16(8):907-14.
  • 1.
    Matthies C, Brill S, Varallyay C, Solymosi L, Gelbrich G, Roosen K, Ernestus RI, Helms J, Hagen R, Mlynski R, Shehata-Dieler W, Müller J. Auditory brainstem implants in neurofibromatosis Type 2: is open speech perception feasible?. J Neurosurg. 2014;120(2):546-58.
2013[ to top ]
  • 1.
    Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B, Investigators AD. Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction: The Aldo-DHF Randomized Controlled Trial. JAMA [Internet]. 2013;309(8):781-9. Available from: https://doi.org/10.1001/jama.2013.905
  • 1.
    Reinsch N, Esser S, Gelbrich G, Brockmeyer N, Potthoff A, Schadendorf D, Erbel R, Neumann T. Valvular manifestations of human immunodeficiency virus infection--results from the prospective, multicenter HIV-HEART study. J Cardiovasc Med (Hagerstown). 2013;14(10):733-9.
  • 1.
    Lainscak M, Farkas J, Inkrot S, Gelbrich G, Neskovic AN, Rau T, Tahirovic E, Töpper A, Apostolovic S, Haverkamp W, Herrmann-Lingen C, Anker SD, Düngen HD. Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis. Int J Cardiol. 2013;163(1):87-92.
  • 1.
    Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N. Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. Clin Res Cardiol. 2013;102(3):203-13.
  • 1.
    Schowalter M, Gelbrich G, Störk S, Langguth JP, Morbach C, Ertl G, Faller H, Angermann CE. Generic and disease-specific health-related quality of life in patients with chronic systolic heart failure: impact of depression. Clin Res Cardiol. 2013;102(4):269-78.
  • 1.
    Lossnitzer N, Herzog W, Störk S, Wild B, Müller-Tasch T, Lehmkuhl E, Zugck C, Regitz-Zagrosek V, Pankuweit S, Maisch B, Ertl G, Gelbrich G, Angermann CE. Incidence rates and predictors of major and minor depression in patients with heart failure. Int J Cardiol. 2013;167(2):502-7.
  • 1.
    Edelmann F, Gelbrich G, Duvinage A, Stahrenberg R, Behrens A, Prettin C, Kraigher-Krainer E, Schmidt AG, Düngen HD, Kamke W, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Wachter R, Pieske B. Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial. Int J Cardiol. 2013;169(6):408-17.
  • 1.
    Wachter R, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Wasser K, Gelbrich G, Hasenfuß G, Stahrenberg R, Liman J, Gröschel K. Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J Neurol. 2013;260(8):2042-5.
  • 1.
    Buder K, Gesierich A, Gelbrich G, Goebeler M. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med. 2013;2(5):674-86.
2012[ to top ]
  • 1.
    Loncar G, von Haehling S, Tahirovic E, Inkrot S, Mende M, Sekularac N, Lainscak M, Apostolovic S, Putnikovic B, Edelmann F, Wachter R, Dimkovic S, Waagstein F, Gelbrich G, Düngen HD. Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial. Clin Biochem. 2012;45(1-2):117-22.
  • 1.
    Zugck C, Franke J, Gelbrich G, Frankenstein L, Scheffold T, Pankuweit S, Duengen HD, Regitz-Zagrosek V, Pieske B, Neumann T, Rauchhaus M, Angermann CE, Katus HA, Ertl GE, Störk S. Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol. 2012;101(4):263-72.
  • 1.
    Rau T, Düngen HD, Edelmann F, Waagstein F, Lainščak M, Dimković S, Apostolović S, Nešković AN, Haverkamp W, Gelbrich G, Eschenhagen T. Impact of the β1-adrenoceptor Arg389Gly polymorphism on heart-rate responses to bisoprolol and carvedilol in heart-failure patients. Clin Pharmacol Ther. 2012;92(1):21-8.
  • 1.
    Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, de Brouwer S, Perrin E, Baumann G, Gelbrich G, Boll H, Honold M, Koehler K, Kirwan BA, Anker SD. Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol. 2012;161(3):143-50.
  • 1.
    Stankovic I, Neskovic AN, Putnikovic B, Apostolovic S, Lainscak M, Edelmann F, Doehner W, Gelbrich G, Inkrot S, Rau T, Herrmann-Lingen C, Anker SD, Düngen HD. Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly. Int J Cardiol. 2012;161(3):160-5.
  • 1.
    Gelbrich G, Edelmann F, Inkrot S, Lainscak M, Apostolovic S, Neskovic AN, Waagstein F, Loeffler M, Anker SD, Dietz R, Düngen HD. Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly. Int J Cardiol. 2012;155(1):160-6.
  • 1.
    Hartwig M, Gelbrich G, Griewing B. Functional orthosis in shoulder joint subluxation after ischaemic brain stroke to avoid post-hemiplegic shoulder-hand syndrome: a randomized clinical trial. Clin Rehabil. 2012;26(9):807-16.
  • 1.
    Edelmann F, Tomaschitz A, Wachter R, Gelbrich G, Knoke M, Düngen HD, Pilz S, Binder L, Stahrenberg R, Schmidt A, März W, Pieske B. Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J. 2012;33(2):203-12.
  • 1.
    Lehmkuhl E, Kendel F, Gelbrich G, Dunkel A, Oertelt-Prigione S, Babitsch B, Knosalla C, Bairey-Merz N, Hetzer R, Regitz-Zagrosek V. Gender-specific predictors of early mortality after coronary artery bypass graft surgery. Clin Res Cardiol. 2012;101(9):745-51.
  • 1.
    Angermann CE, Störk S, Gelbrich G, Faller H, Jahns R, Frantz S, Loeffler M, Ertl G, Failure CNH. Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network for Heart Failure (INH) study. Circ Heart Fail. 2012;5(1):25-3.
  • 1.
    Dekleva M, Düngen HD, Gelbrich G, Incrot S, Suzic Lazic J, Pavlovic Kleut M, Tahirovic E, Waagstein F. Beta blockers therapy is associated with improved left ventricular systolic function and sustained exercise capacity in elderly patients with heart failure. CIBIS-ELD sub-study. Aging Clin Exp Res. 2012;24(6):675-81.
  • 1.
    Wachter R, Lahno R, Haase B, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Gelbrich G, Görlitz A, Kermer P, Vollmann D, Hasenfuß G, Gröschel K, Stahrenberg R. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study. PLoS One. 2012;7(4):e34351.